ExodusPoint Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ExodusPoint Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$33.8M	Buy	178,779 +41,229	+30%	+$7.21M	0.27%	48
2025 Q4	$23.4M	Buy	137,550 +116,542	+555%	+$17.9M	0.18%	86
2025 Q3	$2.77M	Sell	21,008 -11,311	-35%	-$1.36M	0.03%	619
2025 Q2	$3.43M	Sell	32,319 -80,245	-71%	-$8.72M	0.03%	545
2025 Q1	$14M	Buy	+112,564	New	+$14.7M	0.14%	148
2024 Q3	–	Sell	-35,432	Closed	-$3.78M	–	1840
2024 Q2	$3.78M	Buy	+35,432	New	+$3.9M	0.03%	513
2023 Q2	–	Sell	-10,205	Closed	-$1.49M	–	2049
2023 Q1	$1.49M	Buy	+10,205	New	+$1.51M	0.01%	1000
2022 Q4	–	Sell	-30,979	Closed	-$4.13M	–	1872
2022 Q3	$4.13M	Buy	+30,979	New	+$4.71M	0.05%	472
2022 Q1	–	Sell	-12,360	Closed	-$1.57M	–	2423
2021 Q4	$1.57M	Buy	12,360 +6,853	+124%	+$901K	0.02%	860
2021 Q3	$717K	Buy	+5,507	New	+$832K	0.01%	1195
2021 Q2	–	Sell	-2,301	Closed	-$378K	–	2574
2021 Q1	$378K	Buy	+2,301	New	+$379K	0.01%	1527
2020 Q1	–	Sell	-3,592	Closed	-$536K	–	1355
2019 Q4	$536K	Buy	3,592 +95	+3%	+$12.9K	0.01%	821
2019 Q3	$448K	Sell	3,497 -713	-17%	-$95.6K	0.02%	709
2019 Q2	$600K	Buy	+4,210	New	+$566K	0.02%	397

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

ExodusPoint Capital Management's JAZZ Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 30% in Q1 2026, buying an estimated $7.21M and bringing the position to 178,779 shares worth $33.8M. The position accounts for 0.27% of the portfolio, ranked #48.

ExodusPoint Capital Management first reported a position in JAZZ in Q2 2019 and has held it in 14 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

ExodusPoint Capital Management held 178,779 shares of Jazz Pharmaceuticals worth $33.8M as of Q1 2026.
ExodusPoint Capital Management bought 41,229 Jazz Pharmaceuticals shares in Q1 2026, an estimated $7.21M.
Jazz Pharmaceuticals made up 0.27% of ExodusPoint Capital Management's portfolio in Q1 2026, its #48 holding.
ExodusPoint Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 14 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.